PEAK6
CLMT icon

PEAK6’s Calumet Specialty Products CLMT Stock Holding History

PEAK6’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-400
Closed -$7.3K – 2901
2025
Q3 		$7.3K Sell
400
-100
-20% -$1.65K ﹤0.01% 2765
2025
Q2 		$7.88K Sell
500
-4,000
-89% -$50.9K ﹤0.01% 2791
2025
Q1 		$57.1K Buy
+4,500
New +$70.7K ﹤0.01% 2678

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PEAK6's CLMT Position: Q4 2025 in Review

PEAK6 sold out of Calumet Specialty Products (CLMT) in Q4 2025, closing a stake of 131,051 shares — an estimated $2.52M sold.

PEAK6 first reported a position in CLMT in Q3 2025 and held it in 1 quarter. The position peaked at $2.39M in Q3 2025. 140 funds tracked by Wall St. Rank hold CLMT as of Q4 2025.

  • PEAK6 reported no remaining Calumet Specialty Products position as of Q4 2025 after selling out during the quarter.
  • PEAK6 sold 131,051 Calumet Specialty Products shares in Q4 2025, an estimated $2.52M.
  • PEAK6 first reported a position in Calumet Specialty Products in Q3 2025 and held it in 1 quarter.
  • PEAK6's Calumet Specialty Products position peaked at $2.39M in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.